Longhino S, Chatzis LG, Dal Pozzolo R, Peretti S, Fulvio G, La Rocca G, et al. Sjögren’s syndrome: one year in review 2023. Clin Exp Rheumatol. 2023;41(12):2343–56.

PubMed  Google Scholar 

Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American college of rheumatology/european league against rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35–45.

Article  PubMed  Google Scholar 

Yazisiz V, Aslan B, Erbasan F, Uçar İ, Öğüt TS, Terzioğlu ME. Clinical and serological characteristics of seronegative primary Sjögren’s syndrome: a comparative study. Clin Rheumatol. 2021;40(1):221–9.

Article  PubMed  Google Scholar 

Olsson P, Ekblad F, Hassler A, Bengtsson M, Warfvinge G, Mandl T, et al. Complications after minor salivary gland biopsy: a retrospective study of 630 patients from two Swedish centres. Scand J Rheumatol. 2023;52(2):208–16.

Article  CAS  PubMed  Google Scholar 

Baldini C, Berardicurti O, Giacomelli R, Bombardieri M. Is minor salivary gland biopsy still mandatory in Sjogren’s syndrome? Does seronegative Sjogren’s syndrome exist. Autoimmun Rev. 2023;23:103425.

Article  PubMed  Google Scholar 

Zhou C, Gao Y, Ding P, Wu T, Ji G. The role of CXCL family members in different diseases. Cell Death Discov. 2023;9(1):212.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karin N. CXCR3 Ligands in cancer and autoimmunity, chemoattraction of effector T cells, and beyond. Front Immunol. 2020;11:976.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lacotte S, Brun S, Muller S, Dumortier H. CXCR3, inflammation, and autoimmune diseases. Ann N Y Acad Sci. 2009;1173:310–7.

Article  CAS  PubMed  Google Scholar 

Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation-a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40–7.

Article  CAS  PubMed  Google Scholar 

House IG, Savas P, Lai J, Chen AXY, Oliver AJ, Teo ZL, et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin Cancer Res. 2020;26(2):487–504.

Article  CAS  PubMed  Google Scholar 

Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis. 2010;69(6):1103–9.

Article  PubMed  Google Scholar 

Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren’s disease. J Clin Pathol. 1968;21(5):656–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costa S, Quintin-Roué I, Lesourd A, Jousse-Joulin S, Berthelot JM, Hachulla E, et al. Reliability of histopathological salivary gland biopsy assessment in Sjögren’s syndrome: a multicentre cohort study. Rheumatology (Oxford). 2015;54(6):1056–64.

Article  CAS  PubMed  Google Scholar 

Godessart N, Kunkel SL. Chemokines in autoimmune disease. Curr Opin Immunol. 2001;13(6):670–5.

Article  CAS  PubMed  Google Scholar 

Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13(3):272–80.

Article  CAS  PubMed  Google Scholar 

Hua X, Ge S, Zhang M, Mo F, Zhang L, Zhang J, et al. Pathogenic roles of CXCL10 in experimental autoimmune prostatitis by modulating macrophage chemotaxis and cytokine secretion. Front Immunol. 2021;12:706027.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karin N, Razon H. Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity. Cytokine. 2018;109:24–8.

Article  CAS  PubMed  Google Scholar 

Hasegawa H, Inoue A, Kohno M, Muraoka M, Miyazaki T, Terada M, et al. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice. Arthritis Rheum. 2006;54(4):1174–83.

Article  CAS  PubMed  Google Scholar 

Aota K, Kani K, Yamanoi T, Nakashiro KI, Ishimaru N, Azuma M. Distinct regulation of CXCL10 production by cytokines in human salivary gland ductal and acinar cells. Inflammation. 2018;41(4):1172–81.

Article  CAS  PubMed  Google Scholar 

Lee YJ, Scofield RH, Hyon JY, Yun PY, Lee HJ, Lee EY, et al. Salivary chemokine levels in patients with primary Sjogren’s syndrome. Rheumatology (Oxford). 2010;49(9):1747–52.

Article  CAS  PubMed  Google Scholar 

Ogawa N, Kawanami T, Shimoyama K, Ping L, Sugai S. Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjögren’s syndrome. Clin Immunol. 2004;112(3):235–8.

Article  CAS  PubMed  Google Scholar 

Verstappen GM, Pringle S, Bootsma H, Kroese FGM. Epithelial-immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis. Nat Rev Rheumatol. 2021;17(6):333–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

James JA, Guthridge JM, Chen H, Lu R, Bourn RL, Bean K, et al. Unique Sjögren’s syndrome patient subsets defined by molecular features. Rheumatology (Oxford). 2020;59(4):860–8.

Article  CAS  PubMed  Google Scholar 

Padern G, Duflos C, Ferreira R, Assou S, Guilpain P, Maria ATJ, et al. Identification of a novel serum proteomic signature for primary Sjögren’s syndrome. Front Immunol. 2021;12:631539.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elemam NM, Hannawi S, Maghazachi AA. Role of chemokines and chemokine receptors in rheumatoid arthritis. Immunotargets Ther. 2020;9:43–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ibáñez-Cabellos JS, Seco-Cervera M, Osca-Verdegal R, Pallardó FV, García-Giménez JL. Epigenetic regulation in the pathogenesis of Sjögren syndrome and rheumatoid arthritis. Front Genet. 2019;10:1104.

Article  PubMed  PubMed Central  Google Scholar 

Hong J, Cheng H, Wang P, Wu Y, Lu S, Zhou Y, et al. CXCL9 may serve as a potential biomarker for primary Sjögren’s syndrome with extra-glandular manifestations. Arthritis Res Ther. 2024;26(1):26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou J, Zhang X, Yu Q. Plasmacytoid dendritic cells promote the pathogenesis of Sjögren’s syndrome. Biochim Biophys Acta Mol Basis Dis. 2022;1868(2):166302.

Article  CAS  PubMed  Google Scholar 

Zhang L, Zhao L, Du K, Chen J, Ding H, Petersen F, et al. Serum levels of CXCL5 are decreased and correlate with circulating platelet counts in systemic lupus erythematosus. Int J Rheum Dis. 2024;27(3):e15089.

Article  CAS  PubMed  Google Scholar 

Metzemaekers M, Vanheule V, Janssens R, Struyf S, Proost P. Overview of the mechanisms that may contribute to the non-redundant activities of interferon-inducible CXC chemokine receptor 3 ligands. Front Immunol. 2017;8:1970.

Article  PubMed